High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three doses of the SARS-CoV-2 vaccine, according to a new study.
Click here for original story, Mucosal antibodies in the airways protect against omicron infection
Source: ScienceDaily